Waratah Capital Advisors Ltd. Invests $8.14 Million in Danaher Co. (NYSE:DHR)

Waratah Capital Advisors Ltd. purchased a new position in shares of Danaher Co. (NYSE:DHRGet Rating) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 27,745 shares of the conglomerate’s stock, valued at approximately $8,138,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Highlander Capital Management LLC grew its position in shares of Danaher by 100.0% during the 1st quarter. Highlander Capital Management LLC now owns 400 shares of the conglomerate’s stock worth $117,000 after buying an additional 200 shares in the last quarter. Teacher Retirement System of Texas grew its position in shares of Danaher by 4.3% during the 1st quarter. Teacher Retirement System of Texas now owns 238,113 shares of the conglomerate’s stock worth $69,846,000 after buying an additional 9,760 shares in the last quarter. Capital Advisors Ltd. LLC grew its position in shares of Danaher by 25.9% during the 1st quarter. Capital Advisors Ltd. LLC now owns 1,429 shares of the conglomerate’s stock worth $419,000 after buying an additional 294 shares in the last quarter. Lake Street Financial LLC grew its position in shares of Danaher by 15.7% during the 1st quarter. Lake Street Financial LLC now owns 2,239 shares of the conglomerate’s stock worth $657,000 after buying an additional 304 shares in the last quarter. Finally, Meitav Dash Investments Ltd. grew its position in shares of Danaher by 33.5% during the 1st quarter. Meitav Dash Investments Ltd. now owns 42,502 shares of the conglomerate’s stock worth $12,383,000 after buying an additional 10,671 shares in the last quarter. Institutional investors own 78.42% of the company’s stock.

Danaher Stock Performance

Shares of NYSE:DHR traded up $1.05 during trading on Friday, hitting $290.00. The stock had a trading volume of 1,316,343 shares, compared to its average volume of 2,304,426. Danaher Co. has a 12-month low of $233.71 and a 12-month high of $333.96. The stock has a market capitalization of $210.96 billion, a price-to-earnings ratio of 34.16, a price-to-earnings-growth ratio of 2.32 and a beta of 0.86. The company has a quick ratio of 1.32, a current ratio of 1.75 and a debt-to-equity ratio of 0.45. The stock has a 50-day simple moving average of $261.98 and a two-hundred day simple moving average of $268.32.

Danaher (NYSE:DHRGet Rating) last announced its quarterly earnings data on Thursday, July 21st. The conglomerate reported $2.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.35 by $0.41. Danaher had a return on equity of 18.57% and a net margin of 20.61%. The firm had revenue of $7.75 billion during the quarter, compared to analysts’ expectations of $7.29 billion. During the same period last year, the business posted $2.46 earnings per share. The company’s revenue for the quarter was up 7.4% compared to the same quarter last year. On average, equities research analysts expect that Danaher Co. will post 10.39 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, July 29th. Stockholders of record on Friday, June 24th were paid a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 0.34%. The ex-dividend date of this dividend was Thursday, June 23rd. Danaher’s payout ratio is 11.78%.

Insider Transactions at Danaher

In related news, Director Walter G. Lohr sold 3,906 shares of the firm’s stock in a transaction dated Friday, July 22nd. The stock was sold at an average price of $273.84, for a total transaction of $1,069,619.04. Following the sale, the director now directly owns 12,115 shares of the company’s stock, valued at $3,317,571.60. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other Danaher news, EVP Joakim Weidemanis sold 12,000 shares of the firm’s stock in a transaction that occurred on Monday, July 25th. The stock was sold at an average price of $271.13, for a total value of $3,253,560.00. Following the sale, the executive vice president now directly owns 74,398 shares of the company’s stock, valued at $20,171,529.74. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Walter G. Lohr sold 3,906 shares of the firm’s stock in a transaction that occurred on Friday, July 22nd. The shares were sold at an average price of $273.84, for a total value of $1,069,619.04. Following the completion of the sale, the director now directly owns 12,115 shares in the company, valued at $3,317,571.60. The disclosure for this sale can be found here. Company insiders own 11.20% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on DHR. UBS Group upped their price objective on Danaher from $297.00 to $323.00 and gave the stock a “buy” rating in a research note on Thursday, July 28th. Evercore ISI decreased their price objective on Danaher from $320.00 to $280.00 and set an “outperform” rating for the company in a research note on Tuesday, July 5th. KeyCorp decreased their price objective on Danaher from $345.00 to $325.00 and set an “overweight” rating for the company in a research note on Friday, July 22nd. Robert W. Baird upped their price objective on Danaher from $319.00 to $325.00 in a research note on Friday, July 22nd. Finally, Royal Bank of Canada upgraded Danaher from a “sector perform” rating to an “outperform” rating and upped their price objective for the stock from $299.00 to $310.00 in a research note on Wednesday, June 1st. One investment analyst has rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $328.58.

Danaher Company Profile

(Get Rating)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRGet Rating).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.